These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24100249)

  • 21. Neuropeptide Y delays hippocampal kindling in the rat.
    Reibel S; Benmaamar R; Lê BT; Larmet Y; Kalra SP; Marescaux C; Depaulis A
    Hippocampus; 2003; 13(5):557-60. PubMed ID: 12921346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors.
    Ledri LN; Melin E; Christiansen SH; Gøtzsche CR; Cifra A; Woldbye DP; Kokaia M
    Neurobiol Dis; 2016 Feb; 86():52-61. PubMed ID: 26607785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell and gene therapies in epilepsy--promising avenues or blind alleys?
    Löscher W; Gernert M; Heinemann U
    Trends Neurosci; 2008 Feb; 31(2):62-73. PubMed ID: 18201772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neurotrophins NT3 and BDNF induce selective specification of neuropeptide coexpression and neuronal connectivity in arcuate and periventricular hypothalamic neurons in vitro.
    Petit F; Huicq S; Gardette R; Epelbaum J; Loudes C; Kordon C; Faivre-Bauman A
    Neuroendocrinology; 2002 Jan; 75(1):55-69. PubMed ID: 11810035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seizure suppression by GDNF gene therapy in animal models of epilepsy.
    Kanter-Schlifke I; Georgievska B; Kirik D; Kokaia M
    Mol Ther; 2007 Jun; 15(6):1106-13. PubMed ID: 17387333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosinergic signaling in epilepsy.
    Boison D
    Neuropharmacology; 2016 May; 104():131-9. PubMed ID: 26341819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actions of brain-derived neurotrophic factor in slices from rats with spontaneous seizures and mossy fiber sprouting in the dentate gyrus.
    Scharfman HE; Goodman JH; Sollas AL
    J Neurosci; 1999 Jul; 19(13):5619-31. PubMed ID: 10377368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. aFGF, bFGF and NGF differentially regulate neuropeptide expression in dorsal root ganglia after axotomy and induce autotomy.
    Ji RR; Zhang Q; Pettersson RF; Hökfelt T
    Regul Pept; 1996 Oct; 66(3):179-89. PubMed ID: 8916273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The future of epilepsy treatment: focus on adeno-associated virus vector gene therapy.
    McCown TJ
    Drug News Perspect; 2010 Jun; 23(5):281-6. PubMed ID: 20603651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies.
    Brock DC; Demarest S; Benke TA
    Neurotherapeutics; 2021 Jul; 18(3):1445-1457. PubMed ID: 34595733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galanin and galanin receptors in epilepsy.
    Mazarati AM
    Neuropeptides; 2004 Dec; 38(6):331-43. PubMed ID: 15567469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics.
    Metcalf CS; Klein BD; McDougle DR; Zhang L; Kaufmann D; Bulaj G; White HS
    Epilepsia; 2017 Feb; 58(2):239-246. PubMed ID: 28098336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spinal neuropeptide expression and neuropathic behavior in the acute and chronic phases after spinal cord injury: Effects of progesterone administration.
    Coronel MF; Villar MJ; Brumovsky PR; González SL
    Peptides; 2017 Feb; 88():189-195. PubMed ID: 28062253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell and gene therapies for refractory epilepsy.
    Boison D
    Curr Neuropharmacol; 2007; 5(2):115-25. PubMed ID: 18615179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of galanin receptors in anticonvulsant effects of low-frequency stimulation in perforant path-kindled rats.
    Sadegh M; Mirnajafi-Zadeh J; Javan M; Fathollahi Y; Mohammad-Zadeh M; Jahanshahi A; Noorbakhsh SM
    Neuroscience; 2007 Dec; 150(2):396-403. PubMed ID: 17993248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in BDNF-mediated TrkB signaling promotes epileptogenesis in a mouse model of mesial temporal lobe epilepsy.
    Heinrich C; Lähteinen S; Suzuki F; Anne-Marie L; Huber S; Häussler U; Haas C; Larmet Y; Castren E; Depaulis A
    Neurobiol Dis; 2011 Apr; 42(1):35-47. PubMed ID: 21220014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ketogenic diet does not alter brain expression of orexigenic neuropeptides.
    Tabb K; Szot P; White SS; Liles LC; Weinshenker D
    Epilepsy Res; 2004 Nov; 62(1):35-9. PubMed ID: 15519130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adeno-associated viruses containing bFGF or BDNF are neuroprotective against excitotoxicity.
    Schuettauf F; Vorwerk C; Naskar R; Orlin A; Quinto K; Zurakowski D; Dejneka NS; Klein RL; Meyer EM; Bennett J
    Curr Eye Res; 2004 Dec; 29(6):379-86. PubMed ID: 15764082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury.
    Logan A; Ahmed Z; Baird A; Gonzalez AM; Berry M
    Brain; 2006 Feb; 129(Pt 2):490-502. PubMed ID: 16339795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.